• The neuroleptic malignant syndrome (NMS) developed in a 32-year-old man following fluphenazine enanthate administration. Hypercalcemia was initially present, perhaps reflecting release of calcium from skeletal muscle stores. The elevated serum calcium levels support the existence of a peripheral muscle abnormality in the pathogenesis of the NMS and provides another point of similarity between NMS and malignant hyperthermia.
(Arch Intern Med 1985;145:143-144)
Wang RT, Aftergood DE, Carlson HE. Hypercalcemia in the Neuroleptic Malignant Syndrome. Arch Intern Med. 1985;145(1):143–144. doi:10.1001/archinte.1985.00360010181032
Best of JAMA Network 2022
Customize your JAMA Network experience by selecting one or more topics from the list below.